At 38, William Lindley was a father of three kids and passionate about his job in law enforcement. But, after months of ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

An award-winning pathologist who devoted his life to melanoma research became the first person to receive a novel ...

The study results "signal unmet needs and potentially undertreated pain in patients with cancer,” researchers wrote.

The American healthcare system may have a lot of problems, but at the end of the day it is still the envy of the world and has saved countless lives.

Uday R. Popat, MD, discusses promising findings from a phase 2 trial evaluating the JAK inhibitor itacitinib combined with ...

The University of Texas' busiest system by construction projects could be looking at more Houston expansions soon.

Global development program for JNJ-1900 (NBTXR3) proceeding as planned, with opportunity to address one of the largest untapped markets in ...

Houston-based University of Texas MD Anderson Cancer Center broke ground on a new facility in Sugar Land, Texas, set to be ...

The new facility will not only expand the services of MD Anderson's existing Sugar Land location but will also house ...

Toxicity information from phase 3 oncology clinical trials often is incomplete and interpreted in ways that minimize its ...